Business

Exclusive | China challenges US in AI drug race, but rivals still reliant on each other

South China Morning Post
South China Morning Post
0 Min Read
While US biotech firms increase use of Chinese clinical data, Chinese firms need US counterparts for monetisation, investor and scientist says.

This post was originally published on this site

Previous Article Dos Equis revives ‘most interesting man in the world’ commercial as beer sales decline
Next Article I launched my slow fashion business at a surf camp in Bali
This is john jantsch and my guest today is laura ries. Raleigh mayor to formally honor zamboni driver david ayres for leading canes to victory. Veg afghani momos are soft, steamed dumplings filled with spiced vegetables, tossed in a rich….